Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

Tempest Therapeutics Inc. (TPST)

  • Technical Exchange News
  • Jan. 15, 2026, 20:06 UTC
  • 115
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

GRI Bio Inc (GRI)

  • Technical Exchange News
  • Jan. 15, 2026, 20:01 UTC
  • 150
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Adicet Bio Inc (ACET)

  • Technical Exchange News
  • Jan. 15, 2026, 20:00 UTC
  • 103
  • 0 comments

NASDAQ traded attribute type Financial_Status was changed. Previous value: Deficient. New value: Normal.

Comment Full text

Mind Medicine (MNMD)

  • Technical Exchange News
  • Jan. 15, 2026, 09:41 UTC
  • 138
  • 0 comments

Mind Medicine (MNMD) was removed from the list of traded instruments on NASDAQ exchange

Comment Full text

Mind Medicine (MNMD)

  • Technical Exchange News
  • Jan. 15, 2026, 08:35 UTC
  • 32
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: N. New value: Mind Medicine (MindMed) Inc. - Common Shares.

Comment Full text

Mind Medicine (MNMD)

  • Technical Exchange News
  • Jan. 15, 2026, 08:35 UTC
  • 115
  • 0 comments

NASDAQ symbol attribute type Test_mode was changed. Previous value: N. New value: Mind Medicine (MindMed) Inc. - Common Shares.

Comment Full text

Mind Medicine (MNMD)

  • Technical Exchange News
  • Jan. 15, 2026, 08:35 UTC
  • 31
  • 0 comments

NASDAQ symbol attribute type Security_Name was changed. Previous value: Mind Medicine (MindMed) Inc. - Common Shares. New value: Mind Medicine (MindMed) Inc. - Common Shares.

Comment Full text

Estrella Immunopharma Inc. (ESLAW)

  • Technical Exchange News
  • Jan. 15, 2026, 02:44 UTC
  • 35
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Estrella Immunopharma Inc. (ESLA)

  • Technical Exchange News
  • Jan. 15, 2026, 02:44 UTC
  • 36
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text

Capstone Therapeutics Corp (CAPS)

  • Technical Exchange News
  • Jan. 15, 2026, 02:44 UTC
  • 34
  • 0 comments

NASDAQ symbol attribute type Financial_Status was changed. Previous value: Normal. New value: Deficient.

Comment Full text
  • Previous
  • 158
  • 159
  • 160
  • 161
  • 162
  • Next

Search

News categories

  • Technical Exchange News(12370)
  • Event(6229)
  • SEC News(271921)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(158086)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin